Literature DB >> 17435176

The immunophilin FKBP52 specifically binds to tubulin and prevents microtubule formation.

Béatrice Chambraud1, Hamida Belabes, Virginie Fontaine-Lenoir, Arlette Fellous, Etienne Emile Baulieu.   

Abstract

The FK506 binding protein FKBP52 belongs to the large family of immunophilins and is known as a steroid receptor-associated protein. Previous data suggest that FKBP52 is associated with the motor protein dynein and with the cytoskeleton during mitosis. Here we demonstrate a specific and direct interaction between FKBP52 and tubulin. The region of FKBP52 located between aa 267 and 400, which includes the tetratricopeptide repeat domain, is required for tubulin binding. We provide evidence that FKBP52 prevents tubulin polymerization and that an 84 residue sequence located in the C-terminal part of the molecule (aa 375-458) is necessary and sufficient for its microtubule depolymerization activity. In colocalization experiments in PC12 cells, FKBP52 is associated with tubulin in motile cellular compartments. Furthermore, we suggest that, by using siRNA, a decrease of FKBP52 expression in PC12 cells may lead to differentiated cell phenotype characterized by neurite extensions. Collectively, our data define an unexpected property of FKBP52 as a novel regulator of microtubule dynamics. The possible role of microtubule formation and tubulin binding of other immunophilins such as FKBP12 and FKBP51 is discussed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17435176     DOI: 10.1096/fj.06-7667com

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  33 in total

Review 1.  Organization and function of the FKBP52 and FKBP51 genes.

Authors:  Donna L Cioffi; Tina R Hubler; Jonathan G Scammell
Journal:  Curr Opin Pharmacol       Date:  2011-04-21       Impact factor: 5.547

Review 2.  Microbial natural products: molecular blueprints for antitumor drugs.

Authors:  Lesley-Ann Giddings; David J Newman
Journal:  J Ind Microbiol Biotechnol       Date:  2013-09-03       Impact factor: 3.346

Review 3.  FKBP51 and FKBP52 in signaling and disease.

Authors:  Cheryl L Storer; Chad A Dickey; Mario D Galigniana; Theo Rein; Marc B Cox
Journal:  Trends Endocrinol Metab       Date:  2011-08-31       Impact factor: 12.015

Review 4.  The Ubiquitin-Proteasome System and Molecular Chaperone Deregulation in Alzheimer's Disease.

Authors:  Yanuar Alan Sulistio; Klaus Heese
Journal:  Mol Neurobiol       Date:  2015-01-07       Impact factor: 5.590

5.  Fluorescent protein-labeled glucocorticoid receptor alpha isoform trafficking in cultured human trabecular meshwork cells.

Authors:  Adnan Dibas; Ming Jiang; Rafal Fudala; Ignacy Gryczynski; Zygmunt Gryczynski; Abbot F Clark; Thomas Yorio
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-05-17       Impact factor: 4.799

6.  Conserved molecular mechanisms underlying the effects of small molecule xenobiotic chemotherapeutics on cells.

Authors:  Hemant Sarin
Journal:  Mol Clin Oncol       Date:  2015-12-16

7.  Hsp90-binding immunophilin FKBP51 forms complexes with hTERT enhancing telomerase activity.

Authors:  Mariana Lagadari; Nadia R Zgajnar; Luciana I Gallo; Mario D Galigniana
Journal:  Mol Oncol       Date:  2016-05-17       Impact factor: 6.603

Review 8.  The emerging role of peptidyl-prolyl isomerase chaperones in tau oligomerization, amyloid processing, and Alzheimer's disease.

Authors:  Laura J Blair; Jeremy D Baker; Jonathan J Sabbagh; Chad A Dickey
Journal:  J Neurochem       Date:  2015-02-24       Impact factor: 5.372

9.  Targeted ablation reveals a novel role of FKBP52 in gene-specific regulation of glucocorticoid receptor transcriptional activity.

Authors:  Irene M Wolf; Sumudra Periyasamy; Terry Hinds; Weidong Yong; Weinian Shou; Edwin R Sanchez
Journal:  J Steroid Biochem Mol Biol       Date:  2008-11-27       Impact factor: 4.292

Review 10.  Functional diversity and pharmacological profiles of the FKBPs and their complexes with small natural ligands.

Authors:  Andrzej Galat
Journal:  Cell Mol Life Sci       Date:  2012-12-08       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.